MAPKAPK2 and posterior cortical atrophy: In summary, although the tumor suppressive role of MAPKAPK2 remains elusive, our results have implicated miR-96-5p/MAPKAPK2 as a promising therapeutic target for reducing the chemoresistance in AA PCa.